Research and development of advanced learning technologies and teaching methods to identify approaches to extend the benefit of cancer immunotherapy to patients and collaborate to identify new treatment approaches, to rapidly initiate clinical trials and to aggregate and share data to accelerate progress in the field of cancer immunotherapy